SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Brain medicine threat to babies
Mon November 24th - Women who have to take a particular epilepsy drug should be advised not to get pregnant, according to new European guidance. More
Tapeworm found in brain
Mon November 24th - A man in London has been treated for tapeworm in the brain, it has been reported. More
RECENT COMMENTS
On 12/09/2014 Barry Stanley wrote:
The references in this publication did not include... on Effects of binge drinking in p...
On 12/09/2014 Barry Stanley wrote:
The references in this publication did not include... on Effects of binge drinking in p...
On 05/07/2014 paul wrote:
have i got this wrong? Sir simon came out in 201... on Veteran trauma overstated, say...
On 26/06/2014 monica sawitz wrote:
I am a retired RGN, went to GP on 19/5/14, gave me... on Questions over whooping cough ...
On 30/07/2013 chrisdbr wrote:
does this mean that Collagen supplements might be ... on Protein hope for osteoarthriti...
ASTHMA & ALLERGY BOOKS
Clearing the air: An Assessment of Asthma and Indoor Allergens ABC of Asthma For more books click here
ALLERGY NEWS
ALLERGY RSS FEEDS
RSS graphic XML Graphic
ENGLEMED HEALTH NEWS

Promising results for aspirin in fight against cancer

Wednesday March 21st, 2012

Three new studies published today (March 21) support a role for aspirin in the prevention of cancer.

The pill may reduce cancer risk - but may also help stop the disease spreading researchers reported.

Campaigners said it was now time for formal advice to be issued on when to recommend aspirin to deal with cancer risk.

In the first study, Professor Peter Rothwell of Oxford University, UK, and colleagues looked at the short term effect of daily aspirin on cancer risk by analysing 51 previous trials.

This showed that aspirin reduced cancer deaths by 15 per cent, and by up to 37 per cent from five years onwards. The authors write in The Lancet: "Alongside the previously reported reduction by aspirin of the long term risk of cancer death, the short term reductions in cancer incidence and mortality add to the case for daily aspirin in prevention of cancer.

"Prevention of cancer could become the main justification for aspirin use," they add.

The same team also examined the effect of aspirin on the spread of cancer. They took figures from five large trials of daily aspirin and found that after about 6.5 years, aspirin seemed to reduce the risk of metastasis by 36 per cent, and lowered the risk of other cancers beginning.

Aspirin reduced the rate of death due to cancer in patients with certain types of cancer. It was equally effective for older and younger, male and female patients.

The team say: "These findings provide the first proof in man that aspirin prevents distant cancer metastasis. Previous animal studies had shown that platelets play a part in metastasis of cancer via the bloodstream to distant tissues, and that such metastasis might be prevented by aspirin."

Lastly, in The Lancet Oncology, the team describe their systematic review of studies on aspirin and metastases. Both observational studies and randomised trials showed similar drops in risk for most types of cancer.

Professor Peter Johnson, chief clinician of Cancer Research UK, said:  "This is an exciting development. This latest research adds to the evidence that taking a daily dose of aspirin for several years is one of the things that can help to lower the risk of oesophageal, bowel, stomach and lung cancers. 

"This adds to the other established ways of reducing cancer risk – not smoking, keeping a healthy bodyweight and cutting down on alcohol.  It's a good idea for people thinking of taking aspirin to discuss it with their GP, as it can sometimes have side effects such as internal bleeding especially in people over 70."

He added: "Following publication of these studies we now need some definitive advice from the Government as to whether aspirin should be recommended more widely."

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Rothwell, P. M. et al. The Lancet March 21 2012 doi:10.1016/S0140-6736(11)61720-0

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Rothwell, P. M. et al. The Lancet March 21 2012 doi:10.1016/S0140-6736(12)60209-8

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Algra, A. M. and Rothwell, P. M. The Lancet March 21 2012 doi:10.1016/S1470-2045(12)70112-2

Tags: Cancer | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

CATEGORIES